Panel Discussion: What Makes A Good Cardiogenic Shock Center?

Saturday, February 25, 2023

11:10 AM – 11:30 AM ET

Panel Moderator(s)

Daniel Burkhoff, MD, PhD

Director: Heart Failure, Hemodynamics and MCS Research
Cardiovascular Research Foundation
New York, New York, United States

Disclosure(s): Impulse Dynamics: Consultant (Ongoing)
Michael A. Kutcher, MD

Emeritus Professor of Internal Medicine
Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States

No relationships to disclose
Srihari S. Naidu, MD, FSCAI

Director, Cath Labs and HCM Program
Westchester Medical Center
Valhalla, New York, United States

No relationships to disclose

Panel Discussant(s)

Miguel Alvarez Villela, MD

Director, Interventional Heart Failure
Lenox Hill Hospital - Northwell Health
New York, New York, United States

Disclosure(s): Focused Therapeutics, Inc.: Shareholder (Ongoing)
Tariq Enezate, MD

Interventional Cardiology Faculty
OSF-Urbana
Urbana, Illinois, United States

No relationships to disclose
Maya Guglin, MD

Director of Heart Failure/Transplant/MCS
Indiana University
Indianapolis, Indiana, United States

No relationships to disclose
Ben Kenigsberg, MD (he/him/his)

Critical Care Cardiologist
MedStar Washington Hospital Center

Disclosure(s): No financial relationships to disclose
Anita R. Krueger, MD

Cardiothoracic Surgeon
Baylor Scott & White-All Saints Medical Center
Fort Worth, Texas, United States

Disclosure(s): Baylor Heart and Vascular Hospital: Shareholder (Ongoing)

Panel Moderator(s)

Michele D. Voeltz, MD, FACC, FSCAI

Attending Physician
Northside Cardiovascular Institute
Buford, Georgia, United States

Disclosure(s): No relevant disclosure to display

Panel Discussant(s)

Moritz C. Wyler von Ballmoos, MD, PhD, MPH

Associate Professor
University Hospital Zurich
Houston, Texas, United States

Disclosure(s): Boston Scientific Corporation: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing)
Rajan Patel, MD (he/him/his)

Interventional Cardiology Fellowship Program Director & Medical Director CTO PCI program
Ochsner Medical Center, Ochsner Clinical School, Univ. of Queensland
New Orleans, Louisiana, United States

Disclosure(s): Abiomed: Advisory Committee/Board Member (Ongoing), Speakers' Bureau (Ongoing); LivaNova: Speakers' Bureau (Ongoing)
Jolanta M. Siller-Matula, MD PhD

Associate Professor
Medical University of Vienna, Department of Cardiology
Vienna, AUSTRIA, Wien, Austria

Disclosure(s): AOP: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Biosensors: Speakers' Bureau (Terminated, February 8, 2023); Boehringer Ingelheim: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Boston Scientific: Speakers' Bureau (Ongoing); Chiesi: Grants/Research Support Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Daiichi Sankyo: Speakers' Bureau (Ongoing); P&F GmbH: Consultant/Advisory Board (Terminated, February 8, 2023); Pfizer-Bristol Myers Squibb alliance: Speakers' Bureau (Ongoing)
Saraschandra Vallabhajosyula, MD MSc

Assistant Professor of Medicine and Implementation Science
Wake Forest University School of Medicine
High Point, North Carolina, United States

No relationships to disclose

Disclosure(s):

Daniel Burkhoff, MD, PhD: Impulse Dynamics: Consultant (Ongoing)

Miguel Alvarez Villela, MD: Focused Therapeutics, Inc.: Shareholder (Ongoing)

Ben Kenigsberg, MD: No financial relationships to disclose

Anita R. Krueger, MD: Baylor Heart and Vascular Hospital: Shareholder (Ongoing)

Michele D. Voeltz, MD, FACC, FSCAI: No relevant disclosure to display

Moritz C. Wyler von Ballmoos, MD, PhD, MPH: Boston Scientific Corporation: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing)

Rajan Patel, MD: Abiomed: Advisory Committee/Board Member (Ongoing), Speakers' Bureau (Ongoing); LivaNova: Speakers' Bureau (Ongoing)

Jolanta M. Siller-Matula, MD PhD: AOP: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Biosensors: Speakers' Bureau (Terminated, February 8, 2023); Boehringer Ingelheim: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Boston Scientific: Speakers' Bureau (Ongoing); Chiesi: Grants/Research Support Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Daiichi Sankyo: Speakers' Bureau (Ongoing); P&F GmbH: Consultant/Advisory Board (Terminated, February 8, 2023); Pfizer-Bristol Myers Squibb alliance: Speakers' Bureau (Ongoing)